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The current objective of initial resuscitation  of  
patients  with septic shock  is  the  optimisation  of  
general  haemodynamic variables  including  heart  rate,  
mean  arterial  blood  pressure, cardiac output and 
cardiac preload using normalisation of arterial lactate as 
a marker of presumed success [1–3]. However, 
microcirculatory blood flow can remain impaired  despite  
restora-  tion of macro-haemodynamic parameters. Ait-
Oufella et al. clearly showed that persistence of skin 
mottling [4], an increased capillary refill time (CRT) [5] 
and an increased toe-to-room temperature gradient [6] 
were  associated  with  worse  patient  outcomes. 
Similarly, Leone et al. reported that low oxygen tissue 
saturation (StO2) was associated with poor outcomes in 
patients with septic  shock [7]. Few studies have 
assessed a strategy targeting the microcirculation. In  a  
recent paper  published in JAMA, Hernandez  et al. 
performed a multicentre randomised controlled trial 
(ANDROMEDA-SHOCK), conducted in 28 intensive care  
units  (ICU) in 5 South American countries comparing 
peripheral perfusion–targeted (peripheral perfusion  
group)  and  lactate–  targeted (lactate group) 
resuscitation in the early phase  of  septic shock [8]. 
Between March 2017 and March 2018, 424 patients with 
septic shock were randomised to  a  step-by-step  
resuscitation  protocol aimed at normalising CRT (n = 
212) or normalising/ decreasing plasma lactate at a  rate  
exceeding  20%  every  2  hours  (n = 212), over an  8-
hour  intervention  period.  The  primary  outcome  was  
28-day  all-cause  mortality.  Secondary  outcomes  were 
organ dysfunction at 72 hours (using the Sequential 
Organ Failure Assessment (SOFA) score [9]), Day 90 
mortality, organ support-free days (mechanical  
ventilation,  renal  replacement  therapy, and 
vasopressor) within 28 days, and intensive care unit  
(ICU) and hospital lengths of stay. In the final analysis, 
416 patients (98% of those enrolled) were assessed. Day 
28 mortality was 34.9% versus 43.4% in the peripheral 
perfusion and lactate groups, respectively (hazard ratio, 
0.75 [95% CI, 0.55 to 1.02]; P = .06; risk 
difference,   —8.5%   [95%   CI,   —18.2%   to   1.2%]).   
For   secondary 
outcomes, the 72-hour SOFA score was 
significantly lower in the 
peripheral perfusion group (mean SOFA score, 5.6 T 
4.3 vs. 
6.6 T 4.7, P = .045). No significant differences were 
found for other secondary outcomes. The authors 
concluded that a resuscitation strategy targeting CRT 
normalisation compared to a strategy targeting serum 
lactate levels did not reduce 28-day all-cause mortality 
in patients with septic shock. 
The investigators produced a strict protocol to 
reduce variability in patient management, achieving 
less than 15% non- adherence in both groups. The 
control group mortality rate of 43.4% is close to that 
predicted by the Sepsis-3 criteria for septic shock 
[10]. Although the difference in 28-day mortality did 
not reach statistical significance, these findings 
should encourage further assessment of the 
microcirculation in septic shock patients for the 
following reasons: 
 
● the primary goal of this study – a 33% relative 
reduction in mortality rate based on a change in 
initial management strategy – is considerable and 
perhaps unrealistic. This highlights the need for 
appropriate targets in septic shock studies [11], 
and suggests this study was underpowered [12]. 
To show a relative mortality reduction <10%, 
approximately 1500 patients should have been 
included; 
● interestingly, the greater fall in SOFA score at 72 
hours suggests that clinical improvement was 
faster in the peripheral perfusion group. The choice 
of a composite goal including day-28 survival and 
delta SOFA score may have resulted in a 
statistically significant result; 
● in less severely ill patients (APACHE II score < 25 or 
SOFA 
score < 10), the mortality rate was lower in the 
peripheral perfusion group, suggesting that such 
stratification may be therapeutically relevant; 
● a possible explanation for the differences seen 
between the two strategies may relate to the 
timing  of  assessment  (30  vs. 120 minutes in 
the peripheral perfusion and lactate groups, 
respectively). Furthermore, the peripheral 
perfusion strategy was associated with a lower 
volume of fluid resuscitation administered in the 
first 8 hours (2359 T 1344 mL  vs. 2767 T 1749 
mL, P = 0.01). After the first 6 hours of treatment, 
a target of 10% lactate clearance should be used 
with caution [13]. In the present study, some 
patients could have been included after the first 6 
hours, leading to a less efficient application of this 
strategy; 
● this study confirms that a management approach 
during the early phase of septic shock based on a 
reproducible, systematic clinical examination is as 
effective as a biomarker-based 
 
  
 
approach. This could explain the lack of added 
benefit of Early Goal Directed Therapy applied in the 
first 6 hours of septic shock [14]. 
 
In conclusion, this study failed to show outcome 
superiority of a management strategy based on CRT, 
as compared with repeated measurements of serum 
lactate levels. However, its results should at least 
encourage physicians to evaluate the 
microcirculation in patients with septic shock using 
a simple, easy and safe clinical approach aiming at 
assessing peripheral perfusion such as CRT or 
mottling. Whether such a clinical strategy should 
replace or be combined with monitoring of serum 
lactate requires further evaluation. 
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